MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,329,171
Interest income
$42,160
Other income, net
$33,916
Loss from operations
-$3,405,247
Total operating
expenses
$3,405,247
Research and development
$1,724,872
General and
administrative
$1,680,375
Back
Back
Income Statement
source: myfinsight.com
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)